EU plans to boost research and medicines access
This article was originally published in Scrip
Executive Summary
The European Commissionhas laid out a number of ideas intended to reinstate the EU's leading position in pharmaceutical innovation, address problems with access to medicines, and tackle the issues raised by the globalisation of the industry.